A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

White Papers And Industry Reports

Trends, opportunities and the future of drug discovery

Pharmaceutical Artificial Intelligence in 2020: The Sector is Heating Up For Investments

   by Andrii Buvailo    267
Pharmaceutical Artificial Intelligence in  2020: The Sector is Heating Up For Investments

Table of Contents: 

  1. Introduction

  2. The abundance of venture capital, major funding rounds 

  3. New AI-driven biotech startups founded in 2020

  4. Notable AI-focused collaborations involving “big pharma” players

  5. AI adoption by the contract research organizations (CROs) 

  6. AI-designed drug candidates in clinical trials 

  7. The emerging role of AI tech in fighting COVID-19

3 Ways Big Data and Machine Learning Revolutionize Drug Discovery

   by Andrii Buvailo    16150
3 Ways Big Data and Machine Learning Revolutionize Drug Discovery

The Internet media is trending now with numerous mentions of “big data”, “machine learning” and “artificial intelligence” all together destined to revolutionize pharmaceutical and biotech industries and the way drugs are discovered. These new technologies are believed to make drug discovery cheaper, faster, and more productive.

But how is “magic” supposed to happen, after all?

A Market Review Of DNA-encoded Libraries Technology In Drug Discovery

   by Irina Bilous, Andrii Buvailo    4623
A Market Review Of DNA-encoded Libraries Technology In Drug Discovery

The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their own screening programs using DELs, or outsourcing capabilities from specialized DEL providers.

This report provides a bird's view on the DEL market, including a brief summary of DEL technology benefits and limitations, key players, major research deals, and several examples of successful hit discovery programs using DELs. 

Navigating the Challenges of Pharmaceutical Marketing

   by Ben Ramsbottom    4234
Navigating the Challenges of Pharmaceutical Marketing

According to a research report by The Business Research Company, the global pharmaceuticals market was worth $934.8 billion in 2017. This will continue to rise, reaching an incredible $1,170 billion by 2021.

Those who work within the field of pharmaceuticals are well aware of the fragmented and fluctuating nature of the industry. This growing industry is trying to adapt to an ever-changing world in terms of communication, but it is experiencing some roadblocks along the way. We look at some of the most notable challenges facing pharmaceutical marketing today.